Trends in oncological CT imaging: Clinical application of multidetector-row CT and 3D-CT imaging

Computed tomography (CT) plays an essential role in oncological imaging as the modality of screening for malignancies, mapping out the treatment strategy at staging, assessing response to the treatment, and following up patient outcome after the treatment. The advent of multidetector-row CT (MDCT) has brought about dramatic changes in clinical oncological imaging. The very superior temporal and spatial resolution of MDCT has transformed CT imaging from a transaxial cross-sectional technique into an isotropic volume-imaging technique. MDCT facilitates multiphasic contrast-enhanced study for a wide range of body scanning in a single examination, as well as providing flexibility of multidirectional reconstruction and high-quality three-dimensional imaging. With increases in the number of detector rows year by year, systems with 64-detector rows have become commercially available in 2006. The purpose of this article is to review the status of CT imaging in oncological imaging: (1) to outline the impact of MDCT, focusing on oncological imaging and (2) to review the clinical applications of oncological CT imaging with MDCT.